Free Trial
LON:DVNO

Develop North (DVNO) Share Price, News & Analysis

GBX 73 -3.50 (-4.58%)
As of 11:43 AM Eastern

About Develop North Stock (LON:DVNO)

Advanced

Key Stats

Today's Range
73
78
50-Day Range
71.50
82
52-Week Range
63
86
Volume
2,000 shs
Average Volume
20,187 shs
Market Capitalization
£19.00 million
P/E Ratio
43.98
Dividend Yield
5.23%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DVNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Develop North and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DVNO Stock News Headlines

Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
See More Headlines

DVNO Stock Analysis - Frequently Asked Questions

Develop North's stock was trading at GBX 70 at the start of the year. Since then, DVNO stock has increased by 4.3% and is now trading at GBX 73.

Develop North (LON:DVNO) issued its quarterly earnings results on Friday, March, 13th. The company reported $5.46 earnings per share for the quarter. Develop North had a trailing twelve-month return on equity of 2.11% and a net margin of 18.05%.

Shares of DVNO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Develop North investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Bank of America (BAC) and Cal-Maine Foods (CALM).

Company Calendar

Last Earnings
3/13/2026
Today
5/14/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:DVNO
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 1.66
Trailing P/E Ratio
43.98
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£846.72 thousand
Net Margins
18.05%
Pretax Margin
N/A
Return on Equity
2.11%
Return on Assets
1.11%

Debt

Debt-to-Equity Ratio
35.03
Current Ratio
0.10
Quick Ratio
6.87

Sales & Book Value

Annual Sales
£1.32 million
Price / Sales
14.45
Cash Flow
GBX 0.68 per share
Price / Cash Flow
107.50
Book Value
GBX 77.87 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
26,026,000
Free Float
N/A
Market Cap
£19.00 million
Optionable
Not Optionable
Beta
0.16
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (LON:DVNO) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners